| Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis | Journal of the American College of Cardiology | 2017 | 240 |
| Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study) | Circulation | 2017 | 182 |
| Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study | Lancet Diabetes and Endocrinology,the | 2017 | 148 |
| Optimizing Cholesterol Treatment in Patients With Muscle Complaints | Journal of the American College of Cardiology | 2017 | 133 |
| Role of the sympathetic nervous system in regulation of the sodium glucose cotransporter 2 | Journal of Hypertension | 2017 | 97 |
| Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up | Circulation | 2017 | 92 |
| Toward an international consensus-Integrating lipoprotein apheresis and new lipid-lowering drugs | Journal of Clinical Lipidology | 2017 | 80 |
| Factorial Effects of Evolocumab and Atorvastatin on Lipoprotein Metabolism | Circulation | 2017 | 63 |
| Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia | Journal of Clinical Lipidology | 2017 | 53 |
| The renaissance of lipoprotein(a): Brave new world for preventive cardiology? | Progress in Lipid Research | 2017 | 46 |
| CT sizing for left atrial appendage closure is associated with favourable outcomes for procedural safety | European Heart Journal Cardiovascular Imaging | 2017 | 45 |
| Three decades later: The fate of the population of patients who underwent the Atriopulmonary Fontan procedure | International Journal of Cardiology | 2017 | 29 |
| Knowns and unknowns in the care of pediatric familial hypercholesterolemia | Journal of Lipid Research | 2017 | 29 |
| Sympathetic Response and Outcomes Following Renal Denervation in Patients With Chronic Heart Failure: 12-Month Outcomes From the Symplicity HF Feasibility Study | Journal of Cardiac Failure | 2017 | 28 |
| Recent perspectives on the role of nutraceuticals as cholesterol-lowering agents | Current Opinion in Lipidology | 2017 | 27 |
| Prognostic value of segment involvement score compared to other measures of coronary atherosclerosis by computed tomography: A systematic review and meta-analysis | Journal of Cardiovascular Computed Tomography | 2017 | 26 |
| An enquiry based on a standardised questionnaire into knowledge, awareness and preferences concerning the care of familial hypercholesterolaemia among primary care physicians in the Asia-Pacific region: the "Ten Countries Study" | BMJ Open | 2017 | 23 |
| Novel protein biomarkers associated with coronary artery disease in statin-treated patients with familial hypercholesterolemia | Journal of Clinical Lipidology | 2017 | 18 |
| Depicting new pharmacological strategies for familial hypercholesterolaemia involving lipoprotein (a) | European Heart Journal | 2017 | 15 |
| World Heart Federation Cholesterol Roadmap | Global Heart | 2017 | 15 |
| The impact of level of education on vascular events and mortality in patients with type 2 diabetes mellitus: Results from the ADVANCE study | Diabetes Research and Clinical Practice | 2017 | 13 |
| Reverse cascade screening for familial hypercholesterolemia in high-risk Chinese families | Clinical Cardiology | 2017 | 13 |
| Pulmonary vasodilator therapy is associated with greater survival in Eisenmenger syndrome | Heart | 2017 | 13 |
| Beyond cascade screening: detection of familial hypercholesterolaemia at childhood immunization and other strategies | Current Opinion in Lipidology | 2017 | 11 |
| New data on familial hypercholesterolaemia and acute coronary syndromes: The promise of PCSK9 monoclonal antibodies in the light of recent clinical trials | European Journal of Preventive Cardiology | 2017 | 10 |
